Tempest Reports Second Quarter 2025 Financial Results and Provides Business Update GlobeNewswire August 11, 2025 Received clearance to proceed with pivotal trial of amezalpat combination therapy for first-line hepatocellular carcinoma (HCC) in China Granted orphan drug designation from the European Medicines Agency (EMA) for amezalpat for the treatment of patients with HCC Presented new amezalpat […]

Breakfast Celebration Set for August 14, 2025 For 90 years, Social Security has been a promise kept to generations of hardworking Americans. This summer,AARP is joining with communities across the country to celebrate that legacy, while rallying public support to protect its future. AARPMarylandwill host acommunity breakfastonAugust 14, the 90th Anniversary of President Roosevelt signing

(NYSE:GETY), Q2 Revenue Growth of 2.5%, Currency Neutral Growth of 1.8% Q2 Annual Subscription Revenue Growth of 3.7%, Currency Neutral 3.0% Annual Subscription Revenue Rose to 53.5% of Total Revenue in Q2 Reaffirms 2025 Revenue and Adjusted EBITDA Guidance NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) — Getty Images Holdings, Inc. (“Getty Images” or the

Getty Images Reports Second Quarter 2025 Results GlobeNewswire August 11, 2025 Q2 Revenue Growth of 2.5%, Currency Neutral Growth of 1.8% Q2 Annual Subscription Revenue Growth of 3.7%, Currency Neutral 3.0% Annual Subscription Revenue Rose to 53.5% of Total Revenue in Q2 Reaffirms 2025 Revenue and Adjusted EBITDA Guidance NEW YORK, Aug. 11, 2025 (GLOBE

mmWave product revenue increased 45% sequentially and over 200% year-over-year SAN JOSE, CALIFORNIA / ACCESS Newswire / August 11, 2025 / Peraso Inc. (NASDAQ:PRSO) ("Peraso" or the "Company"), a pioneer in mmWave wireless technology solutions, today announced financial results for the second quarter ended June 30, 2025. Management Commentary "Second quarter shipments reflected increased demand,

(NASDAQ:SRPT), SAN FRANCISCO, Aug. 11, 2025 (GLOBE NEWSWIRE) — On July 24, 2025, the European Medicines Agency (“EMA”) recommended the refusal of the marketing authorization for ELEVIDYS, Sarepta's medication intended for the treatment of Duchenne muscular dystrophy. This news prompted another significant decline in the price of Sarepta (NASDAQ: SRPT) shares. The EMA's recommendation follows

(NYSE:FF), CLAYTON, Mo., Aug. 11, 2025 (GLOBE NEWSWIRE) — FutureFuel Corp. (NYSE: FF) (“FutureFuel”), a manufacturer of custom and performance chemicals and biofuels, today announced financial results for the second quarter ended June 30, 2025. Second quarter 2025 Financial Highlights (all comparisons are with the second quarter of 2024) Revenues were $35.7 million, a decrease

(ASX – Trade24:360.AX),(NASDAQ:LIF), Monthly Active Users Reached Approximately 88.0 million; Up 25% Year-Over-Year Record Q2 Global Net Additions of 136 thousand Paying Circles, Reaching 2.5 million TotalTotal Quarterly Revenue Increased 36% Year-Over-Year to $115.4 million Annualized Monthly Revenue Increased 36% Year-Over-Year to $416.1 millionFull-Year Outlook for Revenue and Adjusted EBITDA Raised Based on Year-To-Date Performance

(NASDAQ:MRCC), CHICAGO, Aug. 11, 2025 (GLOBE NEWSWIRE) — Monroe Capital Corporation (NASDAQ: MRCC) today announced its financial results for the second quarter ended June 30, 2025. In a separate joint release issued on August 7, 2025, MRCC and Horizon Technology Finance Corporation (“HRZN”) announced that they have entered into a definitive merger agreement (the “Merger

(NYSE:PNNT), MIAMI, Aug. 11, 2025 (GLOBE NEWSWIRE) — PennantPark Investment Corporation (NYSE: PNNT) announced today its financial results for the third quarter ended June 30, 2025. HIGHLIGHTS Quarter ended June 30, 2025 (unaudited)($ in millions, except per share amounts) Assets and Liabilities: Investment portfolio (1) $ 1,171.6 Net assets $ 480.6 Net asset value per